Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Biomarkers in immunotherapy: literature review and future directions – PubMed

Mashup Score: 3

PubMed - Within the past decade, immunotherapy has revolutionized the treatment of advanced non-small lung cancer (NSCLC). Immune checkpoint inhibitors (ICIs) such as pembrolizumab, nivolumab, atezolizumab, and durvalumab have shown superiority over chemotherapy regimens in patients with programmed death-lig …

Read the full article here

Related Content